11
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Predictors of the failure of treatment with chloroquine in children with acute, uncomplicated, Plasmodium falciparum malaria, in an area with high and increasing incidences of chloroquine resistance

, , , , , , & show all
Pages 535-544 | Published online: 18 Jul 2013

REFERENCES

  • Anon. (1994). Epi Info Version 6. A Word Processing Data Base and Statistics Program for Public Health on IBM-compatible Microcomputers. Atlanta, GA: Centers for Disease Control and Prevention.
  • Anon. (1999). SPSS for Windows Release 10.01 (Standard Version). Chicago, IL: SPSS Inc.
  • Anon. (2004). National Antimalarial Treatment Policy. Abuja, Nigeria: Federal Ministry of Health.
  • Bonnet, S., Gouagna, L. C., Paul, R E., Safeukui, I., Meunier, J.-Y. & Boudin, C. (2003). Estimation of malaria transmission from humans in two neighbour-ing villages in south Cameroon: evaluation and comparison of several indices. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 53–59.
  • Dorsey, G., Kamya, M. R., Ndeezi, G., Barbiye, J. N., Phares, C. R, Olson, J. E., Katabira, E. T. & Rosenthal, P. J. (2000). Predictors of chloroquine treatment failure in children and adults with falci-parum malaria in Kampala, Uganda. American Journal of Tropical Medicine and Hygiene, 62, 686–692.
  • Ezeilo, G. C. (1971). Neutropenia in Africans. Tropical and Geographical Medicine, 23, 264–267.
  • Fontanet, A. L. & Walker, A. M. (1993). Predictors of treatment failure in multiple drug-resistant falci-parum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand. American Journal of Tropical Medicine and Hygiene, 49, 465–472.
  • Githeko, A. K., Brandling-Bennet, A. D., Beier, M., Atieli, F., Owaga, M. & Collins, F. H. (1992). The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 355–358.
  • Hamer, D. H., Macleod, W. B., Addo-Yobo, E., Duggan, C. P., Estrella, B., Fawzi, W. W., Konde-Lule, J. K., Mwanakasale, V., Premji, Z. G., Sempértegui, F., Ssengooba, F. P., Yeboa-Antwi, K. & Simon, J. L. (2003). Age, temperature, and parasitaemia predict chloroquine treatment failure and anaemia in children with uncomplicated Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 422–428.
  • Handunnetti, S. M., Gunewardena, D. M., Pathirana, P. P. S. L., Ekanayake, K., Weerasinghe, S. & Mendis, K. N. (1996). Features of recrudescent chloroquine-resistant Plasmodium falciparum infec-tions confer a survival advantage on parasites and have implications for disease control. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 563–567.
  • Happi, T. C., Thomas, S. M., Gbotosho, G. O., Falade, C. O., Akinboye, D. O., Gerena, L., Hudson, T., Sowunmi, A., Kyle, D. E., Milhous, W., Wirth, D. F. & Oduola, A. M. J. (2003). Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Annals of Tropical Medicine and Parasitology, 97, 439–451.
  • Happi, T. C., Gbotosho, G. O., Sowunmi, A., Falade, C. O., Akinboye, D. O., Gerena, L., Kyle, D. E., Milhous, W., Wirth, D. F. & Oduola, A. M. J. (2004). Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. American Journal of Tropical Medicine and Hygiene, 70, 20–26.
  • Hess, F. I., Iannuzzi, A., Leafasia, J., Cowdrey, D., Nothdurft, H. D., von Sonnenburg, F., Loscher, T. & Rieckmann, K. H. (1996). Risk factors of chloroquine resistance in Plasmodium falciparum. Acta Tropica, 61, 293–306.
  • Ittarat, W., Pickard, A. L., Rattanasinganchan, P., Wilairatana, P., Looareesuwan, S., Emery, K., Low, J., Udomsangpetch, R. & Meshnick, S. R. (2003). Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factor. American Journal of Tropical Medicine and Hygiene, 68, 147–152.
  • Robert, V., Molez, J.-F. & Trape, J.-F. (1996). Gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in West Africa. American Journal of Tropical Medicine and Hygiene, 55,350–351.
  • Salako, L. A. & Aderounmu, A. F. (1987). In vitro chloroquine and mefloquine-resistant Plasmodium falciparum malaria in Nigeria. Lancet, i, 572-573. Salako, L. A., Ajayi, F. O., Sowunmi, A. & Walker, O. (1990). Malaria in Nigeria: a revisit. Annals of Tropical Medicine and Parasitology, 84, 435–445.
  • Shaper, A. G. & Lewis, P. (1971). Genetic neutropenia in people of African origin. Lancet, ii, 1021-1023. Singhasivanon, V., Chongsuphajasiddhi, T., Sabchareon, A., Attanath, P., Webster, H. K., Wernsdorfer, W. H., Sheth, U. K. & Djaja Lika, I. (1992). Pharmacokinetics of mefloquine in children aged 6 to 24 months. European Journal of Drug Metabolism and Pharmacokinetics, 17, 275–279.
  • Sowunmi, A. (2002). A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology, 96, 227–238.
  • Sowunmi, A. (2003). A randomized comparison of chloroquine and chloroquine plus ketotifen, in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology, 97,103–117.
  • Sowunmi, A. & Fateye, B. A. (2003a). Asymptomatic, recrudescent, chloroquine-resistant, Plasmodium fal-ciparum infections in Nigerian children: clinical and parasitological characteristics and implications for transmission of drug-resistant infections. Annals of Tropical Medicine and Parasitology, 97,469–479.
  • Sowunmi, A. & Fateye, B. A. (2003b). Gametocyte sex ratio in children with asymptomatic, recrudescent, pyrimethamine-sulfadoxine-resistant Plasmodium fal-ciparum malaria. Annals of Tropical Medicine and Parasitology, 97,671–682.
  • Sowunmi, A. & Oduola, A. M. J. (1995). Open comparison of mefloquine, mefloquine/sulfadoxine/ pyrimethamine and chloroquine in acute uncompli-cated falciparum malaria in children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 303–305.
  • Sowunmi, A. & Salako, L. A. (1992). Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria. Annals of Tropical Medicine and Parasitology, 86,1–8.
  • Sowunmi, A., Oduola, A. M. J., Ogundahunsi, O. A. T. Falade, C. O., Gbotosho, G. O. & Salako, L. A. (1997). Enhanced efficacy of chloroquine-chlorphe-niramine combination in acute uncomplicated falci-parum malaria in children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 63–67.
  • Sowunmi, A., Oduola, A. M. J., Ogundahunsi, O. A. T. & Salako, L. A. (1998). Enhancement of the antimalarial effect of chloroquine by chlorphenira-mine in vivo. Tropical Medicine and International Health, 3, 177–183.
  • Sowunmi, A., Ayede, A. I., Falade, A. G., Ndikum, V. N., Sowunmi, C. O., Adedeji, A. A., Falade, C. O., Happi, T. C. & Oduola, A. M. J. (2001). Randomized comparison of chloroquine and amo-diaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria children. Annals of Tropical Medicine and Parasitology, 95,549–558.
  • Sowunmi, A., Fateye, B. A., Adedeji, A. A. & Babalola, C. P. (2004a). Plasmodium falciparum hyperparasi-taemia in children: risk factors, treatment outcomes, and gametocytaemia following treatment. Parasite, 11, 317–323.
  • Sowunmi, A., Fateye, B. A., Adedeji, A. A., Fehintola, F. A. & Happi, T. C. (2004b). Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children. Parasitology, 129, 255–262.
  • Ter Kuile, F. O., Luxemburger, C., Nosten, F., Thwai, K. L., Chongsuphajasiddhi, T. & White, N. J. (1995). Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncompli-cated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 660–664.
  • Terlouw, D. J., Courval, J. M., Kolczac, M. S., Rosenberg, O. S., Oloo, A. J., Kager, P. A., Lal, A. A, Nahlen, B. L. & Ter Kuile, F. O. (2003). Treatment history and treatment dose are important determinants of sulfadoxine-pyrimethamine efficacy in children with uncomplicated malaria in western Kenya. Journal of Infectious Diseases, 187, 467–476.
  • Trape, J-.F. (2001). The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene, 64 (Suppl.), 12–17.
  • Trape, J.-F., Pison, G., Preziosi, M.-P., Enel, C., du Lou, A. D., Delaunay, V., Samb, B., Lagarde, E., Molez, J.-F. & Simondon, F. (1998). Impact of chloroqunine resistance on malaria mortality. Life Sciences, 321, 689–697.
  • Von Seidlein, L., Drakeley, C., Greenwood, B., Walraven, G. & Targett, G. (2001). Risk factors for gametocyte carriage in Gambian children. American Journal of Tropical Medicine and Hygiene, 65, 523–526.
  • Walker, O., Dawodu, A. H., Adeyokunnu, A. A., Salako, L. A. & Alván, G. (1983). Plasma chlor-oquine and desthylchloroquine concentrations in children during and after chloroquine treatment for malaria. British Journal of Clinical Pharmacology, 16, 701–705.
  • Walker, O., Salako, L. A., Alván, G., Ericsson, Ö. & Sjöqvist, F. (1987). The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. British Journal of Clinical Pharmacology, 23, 295–301.
  • White, N. J. (1998). Why is it that antimalarial drug treatments do not always work? Annals of Tropical Medicine and Parasitology, 92,449–458.
  • World Health Organization (1973). Chemotherapy of Malaria and Resistance to Antimalarials. Technical Report Series No. 529. Geneva: WHO.
  • World Health Organization (2000). Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94 (Suppl. 1), 1–90.
  • World Health Organization (2001a). The Use of Antimalarial Drugs. Report of a WHO Informal Consultation. Document WHO/CDS/RBM/2001.33. Geneva: WHO.
  • World Health Organization (2001b). The Use of Antimalarial Drugs. Report of a WHO Informal Consultation. Document WHO/CDS/RBM/2001.35. Geneva: WHO.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.